Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Maintaining quality in blood banking

E Harvey1, C Hewison, D E Nevalainen

  • 1National Blood Service, Transfusion Centre, Newcastle-upon-Tyne.

Blood Reviews
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness of a bedaquiline, linezolid, clofazimine 'core' for multidrug-resistant TB.

IJTLD open·2025
Same author

Phenotypic and genotypic resistance to bedaquiline in patients with multi-drug-resistant tuberculosis-experiences from Armenia.

Antimicrobial agents and chemotherapy·2025
Same author

Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy.

IJTLD open·2025
Same author

Outcomes of WHO-conforming, longer, all-oral multidrug-resistant TB regimens and analysis implications.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Concordance of three approaches for operationalizing outcome definitions for multidrug-resistant TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2023
Same author

Integrating hepatitis C treatment into multidrug-resistant TB care.

Public health action·2022

Voluntary accreditation to quality standards like ISO 9000 can help blood transfusion centres meet regulatory requirements. External assessment offers valuable insights, reducing liability and improving patient safety through enhanced quality management.

Area of Science:

  • Healthcare Regulation
  • Quality Management Systems
  • Blood Transfusion Services

Background:

  • Blood transfusion centre regulation often lags behind pharmaceutical industry standards.
  • Existing regulations for pharmaceuticals are being extended to blood transfusion centres (BTCs).
  • Harm caused by blood components may lead to legal redress, depending on adherence to standards.

Purpose of the Study:

  • To explore the role of voluntary accreditation and registration to quality systems standards, such as ISO 9000, for BTCs.
  • To discuss how these standards can benefit BTCs in meeting legislative requirements.
  • To examine the potential of voluntary accreditation as a foundation for Total Quality Management (TQM) programs.

Main Methods:

  • Comparative analysis of ISO 9000, Clinical Pathology Accreditation (CPA), and other quality standards.

Related Experiment Videos

  • Discussion of the advantages of voluntary registration and external assessment for BTCs.
  • Exploration of the progression of pharmaceutical legislation and its implications for BTCs.

    • Main Results:

    • Voluntary accreditation, particularly to ISO 9000, provides a strong base for meeting legislative requirements.
    • External assessment through accreditation offers unique organizational insights.
    • Adherence to recognized standards can reduce liability for BTCs when adverse events occur.

    Conclusions:

    • Voluntary quality standards like ISO 9000 are crucial for BTCs to align with evolving pharmaceutical regulations.
    • Implementing quality systems enhances operational efficiency and staff involvement.
    • Accreditation demonstrates due diligence, mitigating risks and improving patient safety in blood transfusion services.